Rare Anaemias, Sickle-Cell Disease and COVID-19

Rare Anaemias, Sickle-Cell Disease and COVID-19

Authors

  • Joan-Lluis Vives Corrons Institute for Leukaemia Research Josep Carreras ENERCA Coordinator University of Barcelona Catalonia (Spain)
  • Vincenzo De Sanctis Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy

Keywords:

.

Abstract

For rare haematological diseases (RHD), the first question to be answered is if patients with be- nign red blood cell (RBC) defects like haemoglobinopathies, membranopathies and enzymopathies are more vulnerable to COVID-19 infection. Up to now, there is no yet literature on the subject, but, like in general population, the presence of comorbidities such as diabetes, heart disease, pulmonary hypertension, reduced kidney and/or liver function, worsen the effects of the infection. Splenectomy may be an additional risk factor.

References

World Health Organisation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

European Commission. Health and Food Safety Directorate General. “COVID.19 Clinical Management Support System”. e-News. 27/03/2020. https://www.vml.org/enews-march-27-2020/.

COVID-19 and Rare Diseases. Orphanews 27 of March 2020. https://www.drroyspencer.com/2020/03/covid-19-deaths-in-europe-excess-mortality-is-down/.

COVID-19 and Rare Hematological Diseases. EuroBloodNet https://eurobloodnet.eu/covid-19/.

Thalassemia International Federation .The COVID–19 pandemic and haemoglobin disorders. A contribution of Thalassaemia International Federation to its global patients’ community.

https://thalassaemia.org.cy/publications/tif-publications/a-tif-proposed-haemoglobinopathy-patient-pathway-during-the-covid-19-pandemic-2.

. Haemoglobinopathy Co-ordinating Centres. https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f05/.

Downloads

Published

11-05-2020

Issue

Section

CORRESPONDENCE - SPECIAL COVID19

How to Cite

1.
Rare Anaemias, Sickle-Cell Disease and COVID-19. Acta Biomed [Internet]. 2020 May 11 [cited 2024 Mar. 29];91(2):216-7. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9532